| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |